DirectorMoves Sung Lee

Sangamo Therapeutics (NASDAQ: SGMO) $1.06b Sung Lee named CFO x- Gilead SVP FP&A & IR

$$$$ Base $435,000; Sign-on $200,000; Bonus 40% of base

https://investor.sangamo.com/corporate-governance/board-of-directors

https://www.linkedin.com/in/sung-lee-01b890/